Safety assessments and clinical features of PARP inhibitors from real-world data of Japanese patients with ovarian cancer
Abstract Poly (ADP-ribose) polymerase inhibitors have been increasingly used in ovarian cancer treatment. However, the real-world safety data of these drugs in Japanese patients are limited. This retrospective study included 181 patients with ovarian cancer who received olaparib or niraparib at two...
Збережено в:
| Автори: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Nature Portfolio
2024-06-01
|
| Серія: | Scientific Reports |
| Онлайн доступ: | https://doi.org/10.1038/s41598-024-63600-z |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|